This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción 6HL
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Competidores de R1 RCM Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$18.70 |
| 52 Week High | US$25.00 |
| 52 Week Low | US$15.90 |
| Beta | 0.87 |
| 1 Month Change | -7.43% |
| 3 Month Change | -17.26% |
| 1 Year Change | 0% |
| 3 Year Change | 73.82% |
| 5 Year Change | 476.98% |
| Change since IPO | 77.59% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 6HL | DE Healthcare | Mercado DE | |
|---|---|---|---|
| 7D | -2.1% | -1.8% | 1.8% |
| 1Y | 0% | -3.5% | 4.2% |
Rentabilidad vs. Industria: 6HL exceeded the German Healthcare industry which returned -30.4% over the past year.
Rentabilidad vs. Mercado: 6HL exceeded the German Market which returned -20.7% over the past year.
Volatilidad de los precios
| 6HL volatility | |
|---|---|
| 6HL Average Weekly Movement | 7.1% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: 6HL's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: 6HL's weekly volatility (7%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2003 | 21,400 | Joe Flanagan | www.r1rcm.com |
Resumen de fundamentos de R1 RCM Inc.
| Estadísticas fundamentales de 6HL | |
|---|---|
| Capitalización bursátil | €7.86b |
| Beneficios(TTM) | €95.15m |
| Ingresos (TTM) | €1.43b |
82.6x
Ratio precio-beneficio (PE)5.5x
Ratio precio-ventas (PS)¿Está 6HL sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 6HL | |
|---|---|
| Ingresos | US$1.52b |
| Coste de los ingresos | US$1.19b |
| Beneficio bruto | US$325.60m |
| Otros gastos | US$224.80m |
| Beneficios | US$100.80m |
Últimos beneficios comunicados
Mar 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.24 |
| Margen bruto | 21.45% |
| Margen de beneficio neto | 6.64% |
| Ratio deuda/patrimonio | 209.6% |
¿Cómo se ha desempeñado 6HL a largo plazo?
Ver rendimiento histórico y comparativa